» Articles » PMID: 31231305

Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia-A Clinical Neuropsychologist's View on Diagnostic Criteria and Beyond

Overview
Journal Front Neurol
Specialty Neurology
Date 2019 Jun 25
PMID 31231305
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Behavioral variant frontotemporal dementia (bvFTD) is the second leading cognitive disorder caused by neurodegeneration in patients under 65 years of age. Characterized by frontal, insular, and/or temporal brain atrophy, patients present with heterogeneous constellations of behavioral and psychological symptoms among which progressive changes in social conduct, lack of empathy, apathy, disinhibited behaviors, and cognitive impairments are frequently observed. Since the histopathology of the disease is heterogeneous and identified genetic mutations only account for ~30% of cases, there are no reliable biomarkers for the diagnosis of bvFTD available in clinical routine as yet. Early detection of bvFTD thus relies on correct application of clinical diagnostic criteria. Their evaluation however, requires expertise and in-depth assessments of cognitive functions, history taking, clinical observations as well as caregiver reports on behavioral and psychological symptoms and their respective changes. With this review, we aim for a critical appraisal of common methods to access the behavioral and psychological symptoms as well as the cognitive alterations presented in the diagnostic criteria for bvFTD. We highlight both, practical difficulties as well as current controversies regarding an overlap of symptoms and particularly cognitive impairments with other neurodegenerative and primary psychiatric diseases. We then review more recent developments and evidence on cognitive, behavioral and psychological symptoms of bvFTD beyond the diagnostic criteria which may prospectively enhance the early detection and differential diagnosis in clinical routine. In particular, evidence on specific impairments in social and emotional processing, praxis abilities as well as interoceptive processing in bvFTD is summarized and potential links with behavior and classic cognitive domains are discussed. We finally outline both, future opportunities and major challenges with regard to the role of clinical neuropsychology in detecting bvFTD and related neurocognitive disorders.

Citing Articles

AI-assisted neurocognitive assessment protocol for older adults with psychiatric disorders.

Diaz-Guerra D, Hernandez-Lugo M, Broche-Perez Y, Ramos-Galarza C, Iglesias-Serrano E, Fernandez-Fleites Z Front Psychiatry. 2025; 15:1516065.

PMID: 39872430 PMC: 11770049. DOI: 10.3389/fpsyt.2024.1516065.


Neurodegenerative Disorders in Criminal Offending and Cognitive Decline Among Aging Inmates.

Veggi S, Roveta F NeuroSci. 2025; 6(1.

PMID: 39846564 PMC: 11755462. DOI: 10.3390/neurosci6010005.


Barriers and Facilitators to Participation in Clinical Trials Related to Familial Frontotemporal Dementia: A Qualitative Study.

Zammitt D, Brotherhood E, Fearn C, Greaves C, Hayes O, Harding E Mol Genet Genomic Med. 2024; 12(11):e70038.

PMID: 39584282 PMC: 11586684. DOI: 10.1002/mgg3.70038.


Dissecting neural correlates of theory of mind and executive functions in behavioral variant frontotemporal dementia.

Weise C, Engel A, Polyakova M, Wu Q, Mueller K, Herzig S Alzheimers Res Ther. 2024; 16(1):237.

PMID: 39462381 PMC: 11515257. DOI: 10.1186/s13195-024-01596-4.


Iron chelators as a therapeutic option for Alzheimer's disease-A mini-review.

Schreiner O, Schreiner T Front Aging. 2023; 4:1234958.

PMID: 37602277 PMC: 10433644. DOI: 10.3389/fragi.2023.1234958.


References
1.
Vijverberg E, Schouws S, Meesters P, Verwijk E, Comijs H, Koene T . Cognitive Deficits in Patients With Neuropsychiatric Symptoms: A Comparative Study Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders. J Clin Psychiatry. 2017; 78(8):e940-e946. DOI: 10.4088/JCP.16m11019. View

2.
Rosso S, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y . Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003; 126(Pt 9):2016-22. DOI: 10.1093/brain/awg204. View

3.
Matias-Guiu J, Cabrera-Martin M, Valles-Salgado M, Rognoni T, Galan L, Moreno-Ramos T . Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer's disease: clinical assessment and metabolic correlates. Brain Imaging Behav. 2018; 13(3):651-659. DOI: 10.1007/s11682-018-9891-3. View

4.
Fletcher P, Downey L, Golden H, Clark C, Slattery C, Paterson R . Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain. 2015; 138(Pt 11):3360-72. PMC: 4620514. DOI: 10.1093/brain/awv276. View

5.
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges J . Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013; 36(3-4):242-50. DOI: 10.1159/000351671. View